418 results on '"Falcão-Pires, Inês"'
Search Results
2. Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection Fraction
3. Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side
4. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
5. The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity
6. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction
7. The impact of echocardiographic indexation to evaluate cardiac reverse remodeling throughout pregnancy and postpartum
8. The contribution of maternal factors to the oral microbiota of the child: Influence from early life and clinical relevance
9. Fetoplacental endothelial dysfunction in gestational diabetes mellitus and maternal obesity: A potential threat for programming cardiovascular disease
10. Exercise training impacts skeletal muscle remodelling induced by metabolic syndrome in ZSF1 rats through metabolism regulation
11. The PERInatal MYocardial Remodeling (PERIMYR) cohort study protocol: A prospective study of cardiac remodeling and “recovery” in pregnancy as a model to understand the impact of comorbidities in cardiac remodeling and reverse remodeling
12. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
13. Prognostic implications of fibrosis in low risk aortic stenosis patients
14. The Cardiometabolic Impact of Rebaudioside A Exposure during the Reproductive Stage
15. Key Signaling Pathways in the Cardiovascular System
16. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
17. Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
18. Influence of EPICardial adipose tissue in HEART diseases (EPICHEART) study: Protocol for a translational study in coronary atherosclerosis
19. MicroRNAs and ventricular remodeling in aortic stenosis
20. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF
21. Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study
22. Alternatives to animal experimentation in cardiovascular research: human models of disease and biobanking
23. Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
24. Meta-Analysis of Relation of Epicardial Adipose Tissue Volume to Left Atrial Dilation and to Left Ventricular Hypertrophy and Functions
25. Corrigendum to “The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity” [Mol. Cell. Endocrinol. 594 (2024), 112367]
26. Stretch-induced compliance mechanism in pregnancy-induced cardiac hypertrophy and the impact of cardiovascular risk factors.
27. How to use and integrate bioinformatics tools to compare proteomic data from distinct conditions? A tutorial using the pathological similarities between Aortic Valve Stenosis and Coronary Artery Disease as a case-study
28. Gender differences in the association of epicardial adipose tissue and coronary artery calcification: EPICHEART study: EAT and coronary calcification by gender
29. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction
30. Made in the Womb: Maternal Programming of Offspring Cardiovascular Function by an Obesogenic Womb
31. EDTA-functionalized magnetic nanoparticles: A suitable platform for the analysis of low abundance urinary proteins
32. Towards the standardization of stem cell therapy studies for ischemic heart diseases: Bridging the gap between animal models and the clinical setting
33. Alternatives to animal experimentation in cardiovascular research: human models of disease and biobanking.
34. Chapter 18 - Useful bioinformatics approaches for studying pathological conditions characterized by the dysregulation of glucose metabolism
35. Mitochondrial Reversible Changes Determine Diastolic Function Adaptations During Myocardial (Reverse) Remodeling
36. EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases
37. In Vivo Experimental Assessment of Cardiac Function
38. In vitro Experimental Assessment of Cardiac Function
39. Animal Models of Cardiovascular Disease
40. O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure
41. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction
42. EndoProteoFASP as a Tool to Unveil the Peptidome-Protease Profile: Application to Salivary Diagnostics
43. Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload
44. Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy
45. Cardiovascular risk factors during pregnancy impact the postpartum cardiac and vascular reverse remodeling.
46. Diet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword
47. Vertical Transmission and Antifungal Susceptibility Profile of Yeast Isolates from the Oral Cavity, Gut, and Breastmilk of Mother–Child Pairs in Early Life
48. Potential Pathogenic and Opportunistic Oral Bacteria in Early Life: The Role of Maternal Factors in a Portuguese Population
49. MicroRNA-199b is involved in both LV and RV pathological remodeling through distinct molecular mechanisms
50. Can Adiponectin Help us to Target Diastolic Dysfunction?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.